Skip to Main Content

Paper Details

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.
Leukemia
13
2018
Pom, Pomalidomide, dex, dexamethasone, fatigue, multiple, multiple myeloma, myeloma, myelosuppression, patients, pomalidomide, refractory

Datasets